Matinas BioPharma Holdings Inc (MTNB)
0.6159
+0.04
(+6.21%)
USD |
NYAM |
Nov 22, 16:00
0.5922
-0.02
(-3.85%)
After-Hours: 20:00
Matinas BioPharma Holdings Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | 4.285M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 0.2096M |
| March 31, 2018 | 0.1647M |
| December 31, 2017 | 0.1497M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.285M
Minimum
Mar 2023
4.285M
Maximum
Mar 2023
4.285M
Average
4.285M
Median
Mar 2023
Revenue (TTM) Benchmarks
| Equillium Inc | 45.91M |
| Tenon Medical Inc | 3.315M |
| Alphatec Holdings Inc | 572.74M |
| Merck & Co Inc | 63.17B |
| Madrigal Pharmaceuticals Inc | -- |